EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study

Ania Wisniak iD, Virginie Yakam, Sophie Evina Bolo, Alida Moukam, Jessica Sormani iD, Pierre Vassilakos, Bruno Kenfack, Patrick Petignat

BJOG: An International Journal of Obstetrics & Gynaecology · 2025-01 · 132 (2) · 167-177

DOI: 10.1111/1471-0528.17954 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 16.09.2024. Verfasst von Ania Wisniak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics and Pediatrics, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, Abortion, Spontaneous, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation pour la Recherche Nuovo-Soldati, Hôpitaux Universitaires de Genève, Swiss Society for Gynecology and Obstetrics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the impact of thermal ablation (TA) for the treatment of cervical dysplasia on fertility and pregnancy outcomes among women screened for cervical cancer in Cameroon.

Design

Retrospective cohort study.

Setting

Dschang health district, Cameroon. Population Participants aged 30–45 years from two screening trials conducted between 2015 and 2020 in Dschang District Hospital.

Methods

Participants were primarily screened for human papillomavirus infection, triaged by visual inspection and treated by TA if needed. Between October 2021 and March 2022, interviews on subsequent fertility were conducted with participants treated by TA and a control group of untreated women. Main Outcome Measures Pregnancy and miscarriage after screening/treatment.

Results

A total of 760 participants (219 treated and 541 untreated) completed the survey, with a mean follow‐up time of 1297 days. Sixty‐two women (28.3%) treated by TA reported a pregnancy postscreening versus 165 (30.5%) in the control group ( p = 0.550). Adjusted for potential confounders, the hazard ratio of pregnancy for treated compared with untreated women was 0.82 (0.54–1.24, p = 0.350). Among women reporting pregnancies with a known outcome and which were not voluntarily terminated, 18 (35.3%) treated participants had a miscarriage versus 31 (21.4%) in the control group ( p = 0.048). In the adjusted model, no association remained between TA and miscarriage (1.04, 0.39–2.78, p = 0.935).

Conclusions

In our study population, TA did not significantly impact fertility nor miscarriage risk. Our results support the widespread use of TA as a treatment of choice for precancerous cervical lesions in low‐income settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical DysplasiaAbortion, SpontaneousUterine Cervical NeoplasmsHumansFemaleAdultPregnancyRetrospective StudiesMiddle AgedCameroonIncidenceFertilityCohort StudiesPregnancy OutcomeAblation Techniques

Stichwörter der Autor:innen

cervical cancerfertilitymiscarriagepregnancyscreeningthermal ablation

Autor:innen und Institutionen

  • Department of Gynecology, Obstetrics and Pediatrics, Geneva University Hospitals, Geneva, Switzerland.
  • Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Department of Gynecology and Obstetrics, Dschang Regional Hospital Annex, Dschang, Cameroon.
  • Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts, Geneva, Switzerland.
  • Department of Biomedical Sciences, University of Dschang, Dschang, Cameroon.

ORCID-Profile: Ania Wisniak, Jessica Sormani

Förderung

  • Fondation pour la Recherche Nuovo-Soldati
  • Hôpitaux Universitaires de Genève
  • Swiss Society for Gynecology and Obstetrics

Zitieren

APA

Wisniak, A., Yakam, V., Bolo, S. E., Moukam, A., Sormani, J., Vassilakos, P., Kenfack, B., & Petignat, P. (2025). Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology, 132(2), 167-177. https://doi.org/10.1111/1471-0528.17954

Vancouver

Wisniak A, Yakam V, Bolo SE, Moukam A, Sormani J, Vassilakos P, et al. Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2025;132(2):167-177. doi:10.1111/1471-0528.17954

BibTeX
@article{Wisniak2025,
  author = {Wisniak, Ania and Yakam, Virginie and Bolo, Sophie Evina and Moukam, Alida and Sormani, Jessica and Vassilakos, Pierre and Kenfack, Bruno and Petignat, Patrick},
  title = {Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2025},
  volume = {132},
  number = {2},
  pages = {167--177},
  doi = {10.1111/1471-0528.17954}
}
Kostenlos starten →